Vinflunin in the treatment of metastatic urothelial carcinoma of the bladder
MUDr. Jana Katolická, Ph.D.
Onkologicko-chirurgické oddělení, FN u svaté Anny, Brno
Metastatic urothelial carcinoma is a chemotherapy sensitive disease and platinum-based chemotherapy is the standard primary treatment. Vinflunine is a third-generation antimicrotubuline agent of the vinca alkaloid class. In a randomized study a prolongation of overall survival was shown in eligible patients. The data from European studies represents the excellent experience with vinflunine in patients in daily clinical practice.
metastatic urothelial cancer, chemotherapy, vinflunine
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...